Skip to main content

Table 1 Patient’s blood and other specimens tests

From: Peritoneal tuberculosis mimicking carcinomatous ascites in a child living in a low prevalence country: a case report

BLOOD TESTS

 

Reference Range

OTHER TESTS

 

Reference Range

White blood cells (WBC)/μL

6420

5000–15,000

Mantoux TST (mm)

12a

<  10.0

Neutrophils/μL

4980

1300–8500

Fecal calprotectin (μg/g)

<  15.0

<  90.0

Lymphocytes/μL

770

1300–8500

Urinalysis

Negative

Negative

Hemoglobin (g/dL)

11.7

10.5–14.0

Blood culture

Negative

Negative

Platelets/μL

601,000

140,000–440,000

Blood smear

Anisocytosis, microcytosis, poikilocytosis, band cells (rare), manteined formula

 

C-reactive protein (mg/L)

132.3

0.0–5.0

Ascitic fluid analysis

Leukocites 3979/μL Proteins > 1000 mg/dL SAAG < 1.1 g/dL

 

Glucose (mmol/L)

4.5

3.3–6.1

Ascitic fluid citology

Lymphocyte predominance No atipical or bizzare cells

 

Iron (μg/dL)

15.0

30–120

ECG

Negative

Negative

Albumin (g/dL)

3.4

3.4–4.8

Cardiac US

Negative

Negative

Total protein (g/dL)

7.0

6.0–8.0

Interferon Gamma Release Assay - IGRA (first evaluation)

0.39

<0.35

Sodium (mEq/L)

138.0

135–145

Interferon Gamma Release Assay - IGRA (second evaluation)

1.62

<0.35

Potassium (mEq/L)

3.5

3.4–5.5

Ziehl-Nielsen (ZN) staining (3 gastric aspirates) 

Negative

Negative

Chloride (mEq/L)

97.0

96.0–115.0

Culture for acid-alcohol resistant bacilli (3 gastric aspirates)

Negative

Negative

Calcium (mg/dL)

8.8

8.6–11.0

Polymerase Chain Reaction (PCR) - Gene Xpert (3 gastric aspirates)

Negative

Negative

Creatinine (mg/dL)

0.58

0.30–0.80

Vidal agglutination test

Negative

Negative

Urea (mg/dL)

10.0

10.0–38.0

Wright agglutination test

Negative

Negative

eGFR (ml/min/1.73 m2)

121.38

93–129.6

CMV-IgG (U/mL)

<  5.0

<  12.0

AST (U/L)

24.0

5.0–58.0

CMV-IgM (U/mL)

8.07

<  18.0

ALT (U/L)

10.0

8.0–40.0

HSV I/II-IgG

Positive

Negative

GGT (U/L)

13.0

12.0–64.0

HSV I/II-IgM

Negative

Negative

PT- INR

1.1

0.8–1.2

Rubella-IgG (IU/mL)

85.7

<  9.0

Fibrinogen (mg/dL)

413.0

180.0–400.0

Rubella-IgM (IU/mL)

Negative

Negative

Amylase (U/L)

32.0

10.0–80.0

EBV-VCA-IgG (UA/mL)

137

<  20.0

IgG (mg/dL)

1030.0

650.0–1600.0

EBV-VCA-IgM (UA/mL)

<  10.0

<  20.0

IgA (mg/dL)

286

40.0–350.0

   

IgM (mg/dL)

104.0

50.0–300.0

   

tTg IgA (CU)

8.4

<  15.0

   

BetaHCG (mIU/mL)

<  1.0

<  5.0

   

AFP (ng/mL)

0.9

<  15.0

   

CEA (ng/mL)

0.6

0.0–4.0

   

Ca19–9 (U/mL)

14.7

0.0–37.0

   

Ca125 (U/mL)

472

0.0–35.0

   

FSH (mU/mL)

0.2

< 5.0

   

LH (mU/mL)

<  0.1

< 5.1

   

Prolactin (ng/mL)

16.3

3.0–24.0

   

Estradiol (pg/mL)

21.0

5.0–20.0

   

Testosterone (ng/dL)

<  20.0

<  20.0

   
  1. aduring steroid treatment